Similarly, the genomic analyses on receptor tyrosine kinases suggest that genes which are highly activated in response to binding with ligands, like EGFR signaling in cancer, have evolved in a way to be mutable—as measured by proximity to telomeres and A+T content. The gene discussed is NTRK1; the disease is cancer.